Document 2748 DOCN M94A2748 TI Use of a quantitative PCR assay for measurement of HIV RNA in plasma during infection and seroconversion. DT 9412 AU Herman S; Frenkl T; Mulder J; Payne H; Wang Z; Spadoro J; Roche Molecular Systems, Branchburg, NJ. SO Int Conf AIDS. 1994 Aug 7-12;10(1):233 (abstract no. PB0362). Unique Identifier : AIDSLINE ICA10/94369827 AB OBJECTIVE: Use of a Polymerase Chain Reaction (PCR)-based assay for quantitative determination of HIV RNA in plasma specimens during seroconversion, and comparison to Ab and Ag titers, as determined with commercially available test kits. METHODS: A PCR-based assay for quantitation of HIV-1 RNA in plasma has been developed. The assay uses a simplified amplification procedure in which reverse transcription of viral RNA and PCR are carried out in a single reaction by one enzyme. PCR products are detected by hybridization to oligonucleotide probes in a microwell plate format, yielding a colorimetric result. Quantitation is achieved by comparison to an internal RNA standard added to every sample during sample processing. The assay has an analytical sensitivity of 10 HIV RNA molecules, and a dynamic range of greater than 3 orders of magnitude. The assay was used for quantitation of HIV RNA in plasma units collected serially from individual donors during seroconversion, and the results were compared to Ab and Ag titers (specimens, Ab and Ag results kindly provided by Boston Biomedica, Inc., W. Bridgewater, MA, USA). RESULTS: In all 7 donors an acute phase of viral infection was noted by high HIV RNA titers, followed by suppression of RNA titers by 2 to 3 orders of magnitude over periods of 7 to 35 days, coincident with seroconversion. Although the RNA and Ag titers followed the same general patterns, HIV RNA remained detectable by the PCR test after seroconversion in all 7 donors, whereas Ag became undetectable in 6 of the 7 donors. CONCLUSIONS: The quantitative PCR assay detected the acute phase of viral infection, and was sufficiently sensitive to detect viral RNA after seroconversion, when Ag was undetectable, suggesting that the assay may be useful for monitoring viral load in patients with low and high viral burdens. DE AIDS Serodiagnosis Human HIV Antibodies/BLOOD HIV Antigens/BLOOD HIV Infections/*DIAGNOSIS/MICROBIOLOGY HIV Seropositivity/*DIAGNOSIS/MICROBIOLOGY HIV-1/*GENETICS Polymerase Chain Reaction/*METHODS Predictive Value of Tests RNA, Viral/*BLOOD MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).